Simplex Trading’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,300
| Closed | -$3K | – | 11553 |
|
|
2022
Q1 | $3K | Sell |
5,300
-6,200
| -54% | -$5.26K | ﹤0.01% | 9785 |
|
|
2021
Q4 | $14K | Sell |
11,500
-5,800
| -34% | -$10.3K | ﹤0.01% | 8780 |
|
|
2021
Q3 | $46K | Hold |
17,300
| – | – | ﹤0.01% | 7613 |
|
|
2021
Q2 | $47K | Buy |
17,300
+17,030
| +6,307% | +$42.3K | ﹤0.01% | 7721 |
|
|
2021
Q1 | $70K | Sell |
270
-309
| -53% | -$874 | ﹤0.01% | 6219 |
|
|
2020
Q4 | $160K | Buy |
579
+162
| +39% | +$472 | ﹤0.01% | 4900 |
|
|
2020
Q3 | $191K | Buy |
417
+399
| +2,217% | +$1.32K | ﹤0.01% | 4181 |
|
|
2020
Q2 | $4K | Buy |
18
+2
| +13% | +$6 | ﹤0.01% | 7091 |
|
|
2020
Q1 | $2K | Sell |
16
-769
| -98% | -$2.78K | ﹤0.01% | 7257 |
|
|
2019
Q4 | $401K | Buy |
785
+84
| +12% | +$466 | ﹤0.01% | 2968 |
|
|
2019
Q3 | $452K | Sell |
701
-1,167
| -62% | -$8.05K | ﹤0.01% | 2726 |
|
|
2019
Q2 | $1.16M | Buy |
1,868
+1,685
| +921% | +$12.8K | ﹤0.01% | 1770 |
|
|
2019
Q1 | $194K | Buy |
183
+175
| +2,188% | +$1.74K | ﹤0.01% | 3653 |
|
|
2018
Q4 | $6K | Sell |
8
-15
| -65% | -$216 | ﹤0.01% | 6165 |
|
|
2018
Q3 | $44K | Sell |
23
-90
| -80% | -$1.64K | ﹤0.01% | 5296 |
|
|
2018
Q2 | $203K | Buy |
+113
| New | +$1.67K | ﹤0.01% | 3471 |
|
|
2018
Q1 | – | Sell |
-28
| Closed | -$5K | – | 7105 |
|
|
2017
Q4 | $5K | Sell |
28
-121
| -81% | -$5.43K | ﹤0.01% | 4591 |
|
|
2017
Q3 | $36K | Buy |
149
+84
| +129% | +$14.2K | ﹤0.01% | 2607 |
|
|
2017
Q2 | $596K | Buy |
65
+18
| +38% | +$3.15K | 0.03% | 563 |
|
|
2017
Q1 | $192K | Buy |
47
+32
| +213% | +$3.35K | 0.01% | 1243 |
|
|
2016
Q4 | $35K | Hold |
15
| – | – | ﹤0.01% | 2513 |
|
|
2016
Q3 | $13K | Sell |
15
-1
| -6% | -$120 | ﹤0.01% | 3414 |
|
|
2016
Q2 | $3K | Hold |
16
| – | – | ﹤0.01% | 4745 |
|
|
2016
Q1 | $9K | Sell |
16
-11
| -41% | -$1.17K | ﹤0.01% | 3613 |
|
|
2015
Q4 | $27K | Sell |
27
-42
| -61% | -$5.47K | ﹤0.01% | 2452 |
|
|
2015
Q3 | $30K | Buy |
+69
| New | +$8.09K | ﹤0.01% | 2405 |
|
Other funds holding SIOX
JC
CIA
BBA
Simplex Trading's SIOX Position: Q1 2023 in Review
Simplex Trading sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 132 shares — an estimated $56 sold.
Simplex Trading first reported a position in SIOX in Q3 2015 and held it in 25 quarters. The position peaked at $749K in Q2 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.
- Simplex Trading reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Simplex Trading sold 132 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $56.
- Simplex Trading first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 25 quarters.
- Simplex Trading's Sio Gene Therapies Inc. Common Stock position peaked at $749K in Q2 2017.
- 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.
Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.